Transcriptional regulation of energy metabolism in metabolic syndrome.
代谢综合征中能量代谢的转录调控。
基本信息
- 批准号:18390268
- 负责人:
- 金额:$ 11.17万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Insulin resistance is often associated with obesity and can precipitate type 2 diabetes. To date, most known approaches that improve insulin resistance must be preceded by the amelioration of obesity and hepatosteatosis. Here, we show that this provision is not mandatory; insulin resistance and hyperglycemia are improved by the modification of hepatic fatty acid composition, even in the presence of persistent obesity and hepatosteatosis. Mice deficient for Elov 16, the gene encoding the elongase that catalyzes the conversion of palmitate to stearate, were generated and shown to become obese and develop hepatosteatosis when fed a high-fat diet or mated to leptin-deficient ob/ob mice. However, they showed marked protection from hyperinsulinemia, hyperglycemia and hyperleptinemia. Amelioration of insulin resistance was associated with restoration of hepatic insulin receptor substrate-2 and suppression of hepatic protein kinase C e activity resulting in restoration of Akt phosphorylation. Collectively, these data show that hepatic fatty acid composition is a new determinant for insulin sensitivity that acts independently of cellular energy balance and stress. Inhibition of this elongase could be a new therapeutic approach for ameliorating insulin resistance, diabetes and cardiovascular risks, even in the presence of a continuing state of obesity.
胰岛素抵抗通常与肥胖有关,并可导致2型糖尿病。迄今为止,大多数已知的改善胰岛素抵抗的方法必须先改善肥胖和脂肪肝。在这里,我们表明,这一规定是不是强制性的,胰岛素抵抗和高血糖症的改善肝脏脂肪酸组成的修改,即使在存在持续性肥胖和脂肪肝。Elov 16(编码延长酶的基因,该酶催化棕榈酸酯转化为硬脂酸酯)缺陷的小鼠在喂食高脂饮食或与瘦素缺陷的ob/ob小鼠交配时会变得肥胖并发生脂肪肝。然而,它们显示出对高胰岛素血症、高血糖症和高瘦素血症的显著保护。胰岛素抵抗的改善与肝脏胰岛素受体底物2的恢复和肝脏蛋白激酶C e活性的抑制有关,导致Akt磷酸化的恢复。总的来说,这些数据表明肝脏脂肪酸组成是胰岛素敏感性的新决定因素,其作用独立于细胞能量平衡和压力。这种延长酶的抑制可能是一种新的治疗方法,用于改善胰岛素抵抗,糖尿病和心血管风险,即使在存在持续的肥胖状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Even low-intensity and low-volume exercise training may improve insulin resistance in the elderly
即使是低强度和低容量的运动训练也可能改善老年人的胰岛素抵抗
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Kodama S;Shu M;Saito K;Murakami H;Tanaka K;Kuno S;Ajisaka R;Sone Y;Onitake F;Takahashi A;Shimano H;Kondo K;Yamada N;Sone H
- 通讯作者:Sone H
TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes
- DOI:10.1038/nm1334
- 发表时间:2006-01-01
- 期刊:
- 影响因子:82.9
- 作者:Nakagawa, Y;Shimano, H;Yamada, N
- 通讯作者:Yamada, N
Distinct Effects of Pravastain, Atorvastain, and Simvastain on Insulin Secretion from a beta-cell Line, MIN6 Cells.
普伐他汀、阿托伐他汀和辛伐他汀对 β 细胞系 MIN6 细胞胰岛素分泌的独特影响。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ishikawa M;Takahashi A;Yamada N;Shimano H;et. al.
- 通讯作者:et. al.
Crucial role of a long-chain fatty acid elongase, Elov16, in obesity-induced insulin resistance
长链脂肪酸延长酶 Elov16 在肥胖引起的胰岛素抵抗中的关键作用
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Matsuzaka T;Shimano H;Sone H;et. al.
- 通讯作者:et. al.
Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice
- DOI:10.1016/j.cmet.2006.06.009
- 发表时间:2006-08-01
- 期刊:
- 影响因子:29
- 作者:Kato, Toyonori;Shimano, Hitoshi;Yamada, Nobuhiro
- 通讯作者:Yamada, Nobuhiro
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMADA Nobuhiro其他文献
YAMADA Nobuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMADA Nobuhiro', 18)}}的其他基金
Global survey on clinical research supporting and promoting system, aiming Japanese clinical research improvement.
全球临床研究支持和促进体系调查,旨在改善日本临床研究。
- 批准号:
19900005 - 财政年份:2007
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Special Purposes
Animal model for metabolic syndrome and its molecular basis.
代谢综合征动物模型及其分子基础。
- 批准号:
16390260 - 财政年份:2004
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of signaling pathway, cell cycle, and cell growth in atherosclerosis
动脉粥样硬化信号通路、细胞周期和细胞生长的调节
- 批准号:
13470221 - 财政年份:2001
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of fatty acids in pathogenesis of insulin resisitance and atherosclerosis
脂肪酸在胰岛素抵抗和动脉粥样硬化发病机制中的作用
- 批准号:
11470231 - 财政年份:1999
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Molecular biology of form cell generation in atherosclerosis
动脉粥样硬化细胞生成的分子生物学
- 批准号:
09470216 - 财政年份:1997
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of animal models for atherosclerosis and obesity, and molecular mechanism of the common pathway
动脉粥样硬化和肥胖动物模型的建立及其共同途径的分子机制
- 批准号:
09557079 - 财政年份:1997
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gene targeting study on mechanisms for cholesterol accumulation in the artery
动脉胆固醇蓄积机制的基因靶向研究
- 批准号:
07457219 - 财政年份:1995
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of animal models for atheroscherosis and gene therapy
动脉粥样硬化动物模型的建立及基因治疗
- 批准号:
05557049 - 财政年份:1993
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Therapeutic trial of atherosclerosis by M-CSF
M-CSF 治疗动脉粥样硬化的试验
- 批准号:
02557110 - 财政年份:1990
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似海外基金
Role of CD206 surface antigen on M2 macrophages in the development of insulin resistance in the diet-induced obese mice model
M2巨噬细胞上CD206表面抗原在饮食诱导肥胖小鼠模型胰岛素抵抗发展中的作用
- 批准号:
24K19282 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
The Role of IMAT Inflammatory Secretome on Muscle Insulin Resistance
IMAT 炎症分泌组对肌肉胰岛素抵抗的作用
- 批准号:
10749725 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
平滑肌细胞胰岛素抵抗和全身代谢功能障碍在动脉粥样硬化发展和晚期病变发病机制中的作用
- 批准号:
10731723 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
Exploring inter-organ crosstalk to uncover mechanisms that regulate islet function under insulin resistance or obesity
探索器官间串扰以揭示胰岛素抵抗或肥胖下调节胰岛功能的机制
- 批准号:
23H03324 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Developing a blood fatty acid-based algorithm as an early predictor of insulin resistance: Applying machine learning to harmonized data from prospective cohort studies
开发基于血液脂肪酸的算法作为胰岛素抵抗的早期预测因子:将机器学习应用于前瞻性队列研究的统一数据
- 批准号:
10696711 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism
星形胶质细胞胰岛素抵抗诱导青春期延迟和低促性腺激素性性腺功能减退症的神经内分泌缺陷
- 批准号:
10392144 - 财政年份:2022
- 资助金额:
$ 11.17万 - 项目类别:
Elucidating the pathophysiology and molecular mechanisms of renal insulin resistance
阐明肾胰岛素抵抗的病理生理学和分子机制
- 批准号:
10590598 - 财政年份:2022
- 资助金额:
$ 11.17万 - 项目类别: